Evidence map›Paper›PMID 40125737›Full record

ArticleWiadomosci lekarskie (Warsaw, Poland : 1960)2025

Meeting Highlights The 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborations.

Pawel Kalinski, Kathleen M Kokolus, Indu Ahluwalia, Mihaela Balu, Łukasz Balwicki, Brygida Baran, Loretta Beine, Mikhail Berezin, Ioana Berindan-Neagoe, Andriy Beznosenko and 40 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Wiadomosci lekarskie (Warsaw, Poland : 1960), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Pawel KalinskiROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Kathleen M KokolusROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Indu AhluwaliaCENTERS FOR DISESASE CONTROL, ATLANTA, GEORGIA, USA.
Mihaela BaluUNIVERSITY OF CALIFORNIA, IRVINE, IRVINE, CALIFORNIA, USA.
Łukasz BalwickiMEDICAL UNIVERSITY OF GDAŃSK, GDAŃSK, POLAND.
Brygida Baran4CELL THERAPIES, WARSAW, POLAND.
Loretta BeineEMPIRE STATE DEVELOPMENT CORPORATION, ALBANY, NY, USA.
Mikhail BerezinWASHINGTON UNIVERSITY, ST. LOUIS, MO, USA.
Ioana Berindan-NeagoeIULIU HATIEGANU UNIVERISTY OF MEDICINE AND PHARMACY, CLUJ-NAPOCA, ROMANIA.
Andriy BeznosenkoNATIONAL CANCER INSTITUTE, UKRAINE, KYIV, UKRAINE.
Blanka BorowiecPOZNAŃ UNIVERSITY OF MEDICAL SCIENCES, POZNAŃ, POLAND.
Szabolcs BozsányiROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Jonathan BramsonMCMASTER UNIVERSITY, HAMILTON, ON, CANADA.
Brian CzernieckiH. LEE MOFFITT CANCER AND RESEARCH INSTITUTE, TAMPA, FL, USA.
Rūta EverattNATIONAL CANCER INSTITUTE, LITHUANIA, VILNIUS, LITHUANIA.
Wojciech FendlerMEDICAL RESEARCH AGENCY, WARSAW, POLAND; MEDICAL UNIVERSITY OF ŁÓDŹ, ŁÓDŹ, POLAND; DANA-FARBER CANCER INSTITUTE, BOSTON, MA, USA.
Peter ForsythH. LEE MOFFITT CANCER AND RESEARCH INSTITUTE, TAMPA, FL, USA.
Jeffrey E GershenwaldTHE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, HOUSTON, TX, USA.
Maciej GoniewiczROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Khurshid GuruROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Andrew HylandROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Smitha JamesUNIVERSITY AT BUFFALO, BUFFALO, NY, USA.
Iva KiracUNIVERSITY HOSPITAL FOR TUMORS, ZAGREB, CROATIA.
Pawel KoczkodajMARIA SKŁODOWSKA-CURIE NATIONAL RESEARCH INSTITUTE OF ONCOLOGY, WARSAW, POLAND.
Leszek KotulaTHE STATE UNIVERSITY OF NEW YORK UPSTATE MEDICAL UNIVERSITY, SYRACUSE, NY, USA.
Maciej ŁubaMARIA SKŁODOWSKA-CURIE NATIONAL RESEARCH INSTITUTE OF ONCOLOGY, WARSAW, POLAND.
Iwona ŁugowskaMARIA SKŁODOWSKA-CURIE NATIONAL RESEARCH INSTITUTE OF ONCOLOGY, WARSAW, POLAND.
Elizabeth LukeMARIA SKŁODOWSKA-CURIE NATIONAL RESEARCH INSTITUTE OF ONCOLOGY, WARSAW, POLAND.
Cristian LungulescuUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA, CRAIOVA, ROMANIA.
Sandro MatosevicPURDUE UNIVERSITY, WEST LAFAYETTE, IN, USA.
Kaushal NanavatiTHE STATE UNIVERSITY OF NEW YORK UPSTATE MEDICAL UNIVERSITY, SYRACUSE, NY, USA.
Michael NemethROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Karolina NowakMEDICAL RESEARCH AGENCY, WARSAW, POLAND.
Katia NoyesUNIVERSITY AT BUFFALO, BUFFALO, NY, USA.
Mark ParascandolaNATIONAL CANCER INSTITUTE, USA, BETHESDA, MD, USA; NATIONAL INSTITUTES OF HEALTH, BETHESDA, MD, USA.
Waldemar PriebeTHE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, HOUSTON, TX, USA.
Piotr RutkowskiMARIA SKŁODOWSKA-CURIE NATIONAL RESEARCH INSTITUTE OF ONCOLOGY, WARSAW, POLAND.
Mukund SeshadriROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Christine E ShefferROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Ioana-Miruna StanciuCAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIA; ELIAS UNIVERSITY EMERGENCY HOSPITAL, BUCHAREST, ROMANIA.
Joanna StansonROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, USA.
Telisa StewartTHE STATE UNIVERSITY OF NEW YORK UPSTATE MEDICAL UNIVERSITY, SYRACUSE, NY, USA.
Edita SužiedėlienėVILNIUS UNIVERSITY, VILNIUS, LITHUANIA.
Kęstutis SužiedėlisNATIONAL CANCER INSTITUTE, LITHUANIA, VILNIUS, LITHUANIA; VILNIUS UNIVERSITY, VILNIUS, LITHUANIA.
Iryna TanasiichukBOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE.
Anda M VladNATIONAL CANCER INSTITUTE, USA, BETHESDA, MD, USA; NATIONAL INSTITUTES OF HEALTH, BETHESDA, MD, USA.
Wei-Zen WeiKARMANOS CANCER INSTITUTE, DETROIT, MI, USA; WAYNE STATE UNIVERSITY, DETROIT, MI, USA.
Dylan WilliamsEMPIRE STATE DEVELOPMENT CORPORATION, ALBANY, NY, USA.
Malgorzata WojtowiczNATIONAL CANCER INSTITUTE, USA, BETHESDA, MD, USA; NATIONAL INSTITUTES OF HEALTH, BETHESDA, MD, USA.
Tomasz ZdrojewskiMEDICAL UNIVERSITY OF GDAŃSK, GDAŃSK, POLAND; THE POLISH ACADEMY OF SCIENCES, WARSAW, POLAND.

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

The Marie Skłodowska-Curie Symposia on Cancer Research and Care (MSCS-CRC) promote collaborations between cancer researchers and care providers in the United States, Canada and Central and Eastern European Countries (CEEC) to accelerate the development of new cancer therapies, new strategies for early detection and prevention, and improve cancer care and the quality of life for patients and their families. The 4th MSCS-CRC (September 25-27, 2024, Buffalo, New York) brought together 147 participants from the US, Canada, Croatia, Czechia, Lithuania, Poland, Romania and Ukraine, and involved representatives of the US Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI) and their counterparts from Poland, Ukraine Lithuania and other CEECs. They were accompanied by New York State (NYS) and local representatives of the NYS Empire State Development, and of the Translational Research Consortium of Cancer Centers (TRCCC), involving 13 cancer centers from the Northeastern US and Canada, as well as several Pharma and Biotech companies. The 4th Meeting focused on prevention and early detection of smoking- and HPV-related cancers, reducing disparities in cancer detection-, care and outcomes, and increasing the feasibility and reducing costs of high-end treatments, such as cell therapies for patients with advanced cancers. The second focus area were the available sources of funding of regional and international collaborations in these areas. The relevance of the successful model TRCC to promoting the oncology training and research collaborations in the CEE Countries was discussed. The 5th MSCR-CRC meeting will take place September 3-5, 2025, in Warsaw, Poland.

Indexed as

Biomedical ResearchInternational CooperationMedical OncologyNeoplasmsCanadaHumansPolandUnited Statescancer carecancer researchinternational collaborationsregional collaborationsSymposium

Identifiers

PMID40125737
PMCPMC12549008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.